Discover 1,546 paid clinical trials in Boulder, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,546
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: Aurora CO
Sponsor: University of Colorado, Denver
Sex: All
Age: 18+
Code: NCT07030283
Phase 1, Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
for
Prostate Cancer Metastatic
Location: Aurora CO, Highlands Ranch CO, Lone Tree CO, Pierre SD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136624
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Aurora CO, Salt Lake City UT, Omaha NE, Kansas City KS,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Aurora CO, Salt Lake City UT, Scottsdale AZ,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07659782
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate
for
Carcinoma, Squamous Cell
Location: Aurora CO, Dallas TX, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics
Sex: All
Age: 18+
Code: NCT00041613
Phase 3, Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Aurora CO, Dallas TX, San Antonio TX, Glendale CA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Aurora CO, Rochester MN, Los Angeles CA, Houston TX,
Sponsor: TuHURA Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT06947928
Phase 2, Phase 3, Recruiting
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Aurora CO, Iowa City IA, Los Angeles CA,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase 2, Recruiting
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
for
Colorectal Cancer
Location: Aurora CO, Highlands Ranch CO, Texas City TX,
Sponsor: Kahr Bio Australia Pty Ltd
Sex: All
Age: 18+
Code: NCT07235293
Phase 2, Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
for
B-ALL, Hematologic Malignancy, Solid Tumor
Location: Aurora CO, Salt Lake City UT, Los Angeles CA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0 - 30
Code: NCT06579469
Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
for
ALK-positive NSCLC, ALK-Positive Lung Cancer,
Location: Aurora CO, West Valley City UT, St Louis MO, Houston TX,
Sponsor: TRIANA Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07491497
Phase 1, Phase 2, Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Aurora CO, Salt Lake City UT, Omaha NE, Sioux Falls SD,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase 2, Recruiting
Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements
for
Lung Cancer, NSCLC, Brain Metastases
Location: Aurora CO, Stanford CA, Columbus OH
Sponsor: Joshua Palmer
Sex: All
Age: 18+
Code: NCT05987644
Phase 1, Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer